Tag Archives: CYP21A2

F1000 Commentary: Sexual function and surgical outcome in women with congential adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patient’s perception.

Posted on September 11, 2014 by

Nordenstrom A, Frisen L, Falhammar H, Filipsson H, Janson PO, Thoren M, Hagenfeldt K, Nordskjold A. J Clin Endocrinol Metab. 2010 Aug; 95(8):3633-40 Abstract Context: Females with congenital adrenal hyperplasia (CAH) due to a CYP21A2 deficiency are exposed to androgens … Continue reading →

Posted in F1000 Archives | Tagged , , , , | Leave a comment